Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the detailed record of transactions filed by Cohen Fred E, Consejero. Director active across 7 companies, notably CareDx, Inc.. Aggregated, 29 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €1.2m. Activity tracked since 16 June 2021. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Cohen Fred E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Cohen Fred E is Administrateur at CareDx, Inc., Intellia Therapeutics, Inc., Progyny, Inc., FIVE PRIME THERAPEUTICS INC, Kyverna Therapeutics, Inc. and UroGen Pharma Ltd. He has 29 filings in total, and across the sampled recent filings the most frequent transaction nature is Attribution, with EUR 1,198,240 of purchases and EUR 0 of sales between 2016-01-05 and 2026-06-16.